Prediction of Immune-Related Adverse Events Induced by Immune Checkpoint Inhibitors With a Panel of Autoantibodies: Protocol of a Multicenter, Prospective, Observational Cohort Study

Autor: Iñigo Les, Inés Pérez-Francisco, María Cabero, Cristina Sánchez, María Hidalgo, Lucía Teijeira, Virginia Arrazubi, Severina Domínguez, Pilar Anaut, Saioa Eguiluz, Iñaki Elejalde, Alberto Herrera, Mireia Martínez

Publikováno v: Frontiers in Pharmacology, Vol 13 (2022)

Introduction: Immune checkpoint inhibitor (ICI) therapy is markedly improving the prognosis of patients with several types of cancer. On the other hand, the growth in the use of these drugs in oncology is associated with an increase in multiple immun

Externí odkaz: https://doaj.org/article/ae49378928c440ea8eecc760465a2a6a

The C Allele of ATM rs11212617 Associates With Higher Pathological Complete Remission Rate in Breast Cancer Patients Treated With Neoadjuvant Metformin

Autor: Elisabet Cuyàs, Maria Buxó, Maria José Ferri Iglesias, Sara Verdura, Sonia Pernas, Joan Dorca, Isabel Álvarez, Susana Martínez, Jose Manuel Pérez-Garcia, Norberto Batista-López, César A. Rodríguez-Sánchez, Kepa Amillano, Severina Domínguez, Maria Luque, Idoia Morilla, Agostina Stradella, Gemma Viñas, Javier Cortés, Jorge Joven, Joan Brunet, Eugeni López-Bonet, Margarita Garcia, Samiha Saidani, Xavier Queralt Moles, Begoña Martin-Castillo, Javier A. Menendez

Publikováno v: Frontiers in Oncology, Vol 9 (2019)

Background: The minor allele (C) of the single-nucleotide polymorphism (SNP) rs11212617, located near the ataxia telangiectasia mutated (ATM) gene, has been associated with an increased likelihood of treatment success with metformin in type 2 diabete

Externí odkaz: https://doaj.org/article/d2338fd8195c45919755b3df06f89a20

A phase 2 trial of neoadjuvant metformin in combination with trastuzumab and chemotherapy in women with early HER2-positive breast cancer: the METTEN study

Autor: Javier A. Menendez, Samiha Saidani, Sara Verdura, Elisabet Cuyàs, Joan Dorca, Gemma Viñas, Agostina Stradella, Jose Perez-Garcia, Antonio Segura-Carretero, Idoia Morilla, Margarita Garcia, M. Luque, Kepa Amillano, Isabel Alvarez, Maria Buxó, Severina Domínguez, Susana Martínez, Neus Bosch, Begoña Martin-Castillo, Sonia Pernas, Javier Cortes, César A Rodríguez-Sánchez, Elsa Pérez, Eugeni López-Bonet, N. Batista-López, Álvaro Fernández-Ochoa, Jorge Joven, Salvador Fernández-Arroyo

Publikováno v: Dipòsit Digital de la UB
Universidad de Barcelona
Oncotarget
Scopus-Elsevier
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Oncotarget, 2018, vol. 9, núm. 86, p. 35687-35704
Articles publicats (IdIBGi)
Martin Castillo, Begoña Pernas, Sonia Dorca, Joan Álvarez, Isabel Martínez, Susana Pérez Garcia, Jose Manuel Batista López, Norberto Rodríguez Sánchez, César A. Amillano, Kepa Domínguez, Severina Luque, Maria Stradella, Agostina Morilla, Idoia Viñas, Gemma Cortés, Javier Cuyàs, Elisabet Verdura, Sara Fernández Ochoa, Álvaro Fernández Arroyo, Salvador Segura Carretero, Antonio Joven, Jorge Pérez, Elsa Bosch, Neus Garcia, Margarita López Bonet, Eugeni Saidani, Samiha Buxó Pujolràs, Maria Menéndez Menéndez, Javier Abel 2018 A phase 2 trial of neoadjuvant metformin in combination with trastuzumab and chemotherapy in women with early HER2-positive breast cancer: the METTEN study Oncotarget 9 86 35687 35704
DUGiDocs – Universitat de Girona
instname

The METTEN study assessed the efficacy, tolerability, and safety of adding metformin to neoadjuvant chemotherapy plus trastuzumab in early HER2-positive breast cancer (BC). Women with primary, non-metastatic HER2-positive BC were randomized (1:1) to

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d91433b4b411119bbcc0dd3f3b0d404
https://doi.org/10.18632/oncotarget.26286

Valoración del coste económico del cáncer colorrectal según estadio tumoral

Autor: Jose Errasti, Gilen Mar-Barrutia, José Miguel Martinez-Llorente, Juan José García-Albás, Arantzazu Arrospide, Javier Mar, Severina Domínguez, Myriam Soto-Gordoa

Publikováno v: Cirugía Española. 95:89-96

Resumen Introduccion El objetivo de este trabajo fue medir el coste del tratamiento del cancer colorrectal en un hospital del sistema sanitario publico vasco segun el estadio clinico. Metodos Se recogieron de forma retrospectiva variables demografica

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::33a888dec542529fc14fee47938e75c3
https://doi.org/10.1016/j.ciresp.2017.01.001

The

Autor: Elisabet, Cuyàs, Maria, Buxó, Maria José, Ferri Iglesias, Sara, Verdura, Sonia, Pernas, Joan, Dorca, Isabel, Álvarez, Susana, Martínez, Jose Manuel, Pérez-Garcia, Norberto, Batista-López, César A, Rodríguez-Sánchez, Kepa, Amillano, Severina, Domínguez, Maria, Luque, Idoia, Morilla, Agostina, Stradella, Gemma, Viñas, Javier, Cortés, Jorge, Joven, Joan, Brunet, Eugeni, López-Bonet, Margarita, Garcia, Samiha, Saidani, Xavier, Queralt Moles, Begoña, Martin-Castillo, Javier A, Menendez

Publikováno v: Frontiers in Oncology

Background: The minor allele (C) of the single-nucleotide polymorphism (SNP) rs11212617, located near the ataxia telangiectasia mutated (ATM) gene, has been associated with an increased likelihood of treatment success with metformin in type 2 diabete

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::16b426e4f77db00e9a59015579d96a55
https://pubmed.ncbi.nlm.nih.gov/30984619